A review of phosphodiesterase type 5 inhibitors

  • N Schellack
  • A Agoro

Abstract

Currently, three phosphodiesterase type 5 (PDE5) inhibitors are available for clinical use in South Africa; sildenafil, vardenafil and tadalafil. The PDE  inhibitors are used in males to treat erectile dysfunction. However, sildenafil is also registered for use in the treatment of pulmonary hypertension. Newer  studies are investigating the use of these drugs for other conditions, including hypertension, ischaemia or reperfusion injury, myocardial infarction, cardiac hypertrophy, heart failure and other peripheral circulatory conditions, e.g. Raynaud’s disease. The article provides a broad overview of the mechanism of action, indications, pharmacokinetics and side-effects of these agents.
Published
2014-07-18
Section
Articles

Journal Identifiers


eISSN: 2078-6204
print ISSN: 2078-6190